Answers are grounded in this paper and cite their sources.
Observational study identifies cumulative cefepime exposure increasing ertapenem-resistant infections in immunocompromised patients, suggesting a need for vigilance.
Non-carbapenemase-producing (non-CP) carbapenem-resistant Enterobacterales (CRE) are an important classification of CRE. Increasing rates of non-CP CRE that display carbapenem susceptibility discordance (CSD-E; ertapenem-resistant, meropenem susceptible) have been observed globally and at our institution. Our article aims to characterize risk factors, including cumulative antibiotic exposure, leading to carbapenem susceptibility discordant Enterobacterales (CSD-E) bloodstream infection (BSI) in immunocompromised patients with a history of Enterobacterales BSI. In addition, we analyzed paired whole-genome sequencing data to assess antimicrobial gene content for mechanistic rationales supporting our clinical findings. The risk factors for CSD-E development identified in this study require further validation in multicenter cohorts.
No takes yet. Share an insight, caveat, or question.
Stäbler et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: